Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)

Eric L. Simpson, Seth Forman, Jonathan I. Silverberg, Matthew Zirwas, Emanual Maverakis, George Han, Emma Guttman‐Yassky, Daniel Marnell, Robert Bissonnette, Jill Waibel, Fabio P. Nunes, Amy M. DeLozier, Robinette Angle, Margaret Gamalo, Katrin Holzwarth, Orin M. Goldblum, Jinglin Zhong, Jonathan Janes, Kim Papp